People who base their health choices on what they found on the internet instead of talking to their doctors have long since been regarded with a generous amount of disdain. However, a new study suggests that using web-based counseling is actually just as effective at lowering blood pressure as taking actual medication.
The study was presented during the 66th Annual Scientific Session and Expo, which was held in Washington, D.C., The Washington Post reports. It looked at the cases of patients who enrolled in the website Heart and Stroke Association of Canada, where over 264 people diagnosed with high blood pressure and with an average age of 56 years old were tracked.
The groups were divided based on Web-based lifestyle counseling and Web-based control intervention, both of which involved different approaches to addressing systolic blood pressure. It would seem that the former method yielded better results than the latter, but both systems did accomplish the goal of reducing mmHg levels in the patients.
Robert P. Nolan from the Peter Munk Cardiac Center at the University Health Network is the lead author of the study and he calls web-based counseling e-Counseling. He confirmed that this method had similar results compared to having the patients take drugs in order to control their blood pressure.
“The electronic counseling (e-Counseling) intervention had an effect similar to that of adding an additional blood-pressure-lowering medication,” Prof. Nolan said.
As to what this so-called e-Counseling even involves, patients are given a variety of resources in order to help them cope with their health condition. These include interactive online content, as well as a few video and audio resources, MedicalXpress reports. Based on the results that the researchers got from the study, it would seem that the more engaging content yielded the best improvements in lowering blood pressure among the patients.


SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Trump Plans Federal AI Force and AI Czar
Anthropic’s Claude Discovers CRISPR-Like Enzyme System
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Meta Partners With Shopify to Bring Shop Pay Checkout to Muse AI
SpaceX Nasdaq 100 Weight to More Than Double in Rebalance
BlackBerry Shares Rise as Q2 Earnings, Revenue Beat Estimates
Former OpenAI Data Center Chief Chris Malone Joins Nvidia
OpenAI Agent Breaches Australia Medicare Data Portal
GLP-1 Weight-Loss Drug Use Surges Among U.S. Children
SoftBank Raises $11.1 Billion in Bond Sale to Fund OpenAI Investment
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
Westinghouse Targets $50 Billion Valuation in U.S. IPO
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss 



